Cytosorbents Corp
CTSO
50 hedge funds and large institutions have $16.7M invested in Cytosorbents Corp in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 6 closing their positions.
1.15% less ownership
Funds ownership: 34.84% → 33.69% (-1.1%)
7% less funds holding
Funds holding: 54 → 50 (-4)
13% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 16
17% less capital invested
Capital invested by funds: $20.2M → $16.7M (-$3.48M)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
+$399K |
| 2 |
AC
Avenir Corporation
Alexandria,
Virginia
|
+$118K |
| 3 |
Neuberger Berman Group
New York
|
+$108K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$71.4K |
| 5 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$558K |
| 2 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
-$369K |
| 3 |
Morgan Stanley
New York
|
-$120K |
| 4 |
Renaissance Technologies
New York
|
-$93.1K |
| 5 |
LWA
Ledgewood Wealth Advisors
Exeter,
New Hampshire
|
-$81K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
51
Virtu Financial
New York
| – | -$22K | -20,215 | Closed |
|
52
Charles Schwab
San Francisco,
California
| – | -$17.8K | -15,994 | Closed |
|
53
US Bancorp
Minneapolis,
Minnesota
| – | -$11.1K | -10,000 | Closed |
|
|
ASN
54
Advisory Services Network
Atlanta,
Georgia
| – | -$2.44K | -2,200 | Closed |
|
55
Simplex Trading
Chicago,
Illinois
| – | -$817 | -839 | -58% |
|
56
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$14 | +14 | +18% |
|
CTSO Hedge Fund Activity: Q1 2024 in Review
50 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2024, worth a combined $16.7M — down 17% from $20.2M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CTSO and 2 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 14 added.
The largest buyer was CM Management, adding an estimated $399K. The largest seller was Granahan Investment Management, cutting an estimated $558K.
- 50 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2024, down from 54 in Q4 2023.
- Funds reported $16.7M of Cytosorbents Corp stock for Q1 2024, down 17% quarter-over-quarter.
- 2 funds opened new Cytosorbents Corp positions in Q1 2024 and 6 closed out, a net change of -4 holders.
- The largest Cytosorbents Corp buyer in Q1 2024 was CM Management, an estimated $399K added.
- The largest Cytosorbents Corp seller in Q1 2024 was Granahan Investment Management, an estimated $558K sold.
Based on aggregated 13F filings for Q1 2024.